Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boston Medical Investors was a Boston-based venture capital firm that specialized in early-stage investments within the healthcare, biotechnology, and pharmaceutical sectors. Founded in 1994 by biotech pioneer Bob Carpenter, the firm focused on identifying and supporting innovative medical technologies and therapeutic platforms. During its active years, the firm participated in the early funding of several notable life science companies, including Moderna, Hydra Biosciences, and Peptimmune. The firm played a significant role in the Boston biotech ecosystem for over two decades before its principal transitioned to other leadership and board roles in the industry around 2015.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boston Medical Investors.